Updated Jul 16, 2026
Thomas Stephen Basil has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $879K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-27 | CLYM | Climb Bio, Inc. | S — Open-market sale [10b5-1] | 16.3K | $7.01 | $114K |
| 2026-02-27 | CLYM | Climb Bio, Inc. | S — Open-market sale [10b5-1] | 33.7K | $7.00 | $236K |
| 2026-02-17 | CLYM | Climb Bio, Inc. | S — Open-market sale [10b5-1] | 10.0K | $5.81 | $58K |
| 2026-02-17 | CLYM | Climb Bio, Inc. | S — Open-market sale [10b5-1] | 90.0K | $5.23 | $471K |
| 2025-08-07 | CLYM | Climb Bio, Inc. | A — Grant or award | 100.4K | $0.00 | |
| 2025-06-27 | CLYM | Climb Bio, Inc. | M — Option exercise | 25.1K | — |
Thomas Stephen Basil is a corporate insider — currently tracked as Insider of Climb Bio, Inc. (CLYM). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($879K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Thomas Stephen Basil profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.